Cigna Investments’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $420K | Sell |
4,965
-140
| -3% | -$11.3K | 0.05% | 291 |
|
|
2026
Q1 | $361K | Sell |
5,105
-319
| -6% | -$23.9K | 0.06% | 305 |
|
|
2025
Q4 | $428K | Hold |
5,424
| – | – | 0.06% | 262 |
|
|
2025
Q3 | $447K | Sell |
5,424
-66
| -1% | -$5.19K | 0.06% | 262 |
|
|
2025
Q2 | $441K | Sell |
5,490
-348
| -6% | -$26.9K | 0.08% | 246 |
|
|
2025
Q1 | $469K | Sell |
5,838
-170
| -3% | -$14.1K | 0.09% | 229 |
|
|
2024
Q4 | $491K | Sell |
6,008
-197
| -3% | -$16.4K | 0.09% | 220 |
|
|
2024
Q3 | $512K | Sell |
6,205
-88
| -1% | -$6.57K | 0.09% | 216 |
|
|
2024
Q2 | $441K | Sell |
6,293
-307
| -5% | -$21.9K | 0.08% | 233 |
|
|
2024
Q1 | $489K | Sell |
6,600
-211
| -3% | -$14.7K | 0.09% | 215 |
|
|
2023
Q4 | $451K | Sell |
6,811
-95
| -1% | -$5.95K | 0.09% | 222 |
|
|
2023
Q3 | $435K | Sell |
6,906
-889
| -11% | -$55.4K | 0.1% | 207 |
|
|
2023
Q2 | $440K | Sell |
7,795
-226
| -3% | -$12.5K | 0.08% | 254 |
|
|
2023
Q1 | $465K | Sell |
8,021
-156
| -2% | -$10.5K | 0.09% | 229 |
|
|
2022
Q4 | $592K | Sell |
8,177
-90
| -1% | -$6.45K | 0.12% | 177 |
|
|
2022
Q3 | $502K | Sell |
8,267
-525
| -6% | -$33.5K | 0.11% | 190 |
|
|
2022
Q2 | $552K | Sell |
8,792
-3,532
| -29% | -$234K | 0.11% | 187 |
|
|
2022
Q1 | $866K | Sell |
12,324
-3,949
| -24% | -$267K | 0.11% | 186 |
|
|
2021
Q4 | $1.02M | Sell |
16,273
-6,076
| -27% | -$381K | 0.08% | 200 |
|
|
2021
Q3 | $1.38M | Sell |
22,349
-750
| -3% | -$45.2K | 0.1% | 175 |
|
|
2021
Q2 | $1.38M | Sell |
23,099
-3,939
| -15% | -$250K | 0.1% | 175 |
|
|
2021
Q1 | $1.64M | Buy |
27,038
+416
| +2% | +$23K | 0.11% | 159 |
|
|
2020
Q4 | $1.25M | Buy |
26,622
+1,881
| +8% | +$81.5K | 0.1% | 179 |
|
|
2020
Q3 | $920K | Sell |
24,741
-99
| -0.4% | -$3.76K | 0.09% | 201 |
|
|
2020
Q2 | $908K | Buy |
24,840
+2,933
| +13% | +$102K | 0.09% | 219 |
|
|
2020
Q1 | $670K | Buy |
21,907
+1,250
| +6% | +$55.4K | 0.09% | 254 |
|
|
2019
Q4 | $1.03M | Sell |
20,657
-2,864
| -12% | -$138K | 0.11% | 233 |
|
|
2019
Q3 | $1.1M | Sell |
23,521
-1,550
| -6% | -$73.9K | 0.11% | 228 |
|
|
2019
Q2 | $1.24M | Sell |
25,071
-950
| -4% | -$44.7K | 0.13% | 198 |
|
|
2019
Q1 | $1.11M | Sell |
26,021
-1,229
| -5% | -$54.3K | 0.12% | 212 |
|
|
2018
Q4 | $1.12M | Sell |
27,250
-75
| -0.3% | -$3.22K | 0.09% | 152 |
|
|
2018
Q3 | $1.13M | Sell |
27,325
-3,067
| -10% | -$140K | 0.09% | 168 |
|
|
2018
Q2 | $1.33M | Sell |
30,392
-6,059
| -17% | -$282K | 0.1% | 189 |
|
|
2018
Q1 | $1.67M | Sell |
36,451
-400
| -1% | -$19.4K | 0.11% | 139 |
|
|
2017
Q4 | $1.86M | Sell |
36,851
-2,426
| -6% | -$128K | 0.12% | 129 |
|
|
2017
Q3 | $2.04M | Sell |
39,277
-5,475
| -12% | -$267K | 0.14% | 111 |
|
|
2017
Q2 | $2.19M | Sell |
44,752
-3,182
| -7% | -$148K | 0.15% | 99 |
|
|
2017
Q1 | $2.26M | Buy |
47,934
+4,234
| +10% | +$202K | 0.16% | 98 |
|
|
2016
Q4 | $2.1M | Buy |
+43,700
| New | +$2M | 0.23% | 88 |
|
Other funds holding MET
AAMU
FMLI
WCM
AV
MIF
EIP
FMII
P
Cigna Investments's MET Position: Q2 2026 in Review
Cigna Investments reduced its MetLife (MET) stake by 2.7% in Q2 2026, selling an estimated $11.3K and leaving 4,965 shares worth $420K. The position accounts for 0.05% of the portfolio, ranked #291.
Cigna Investments first reported a position in MET in Q4 2016 and has held it in 39 quarters since. The position peaked at $2.26M in Q1 2017. 423 funds tracked by Wall St. Rank hold MET as of Q2 2026.
- Cigna Investments held 4,965 shares of MetLife worth $420K as of Q2 2026.
- Cigna Investments sold 140 MetLife shares in Q2 2026, an estimated $11.3K.
- MetLife made up 0.05% of Cigna Investments's portfolio in Q2 2026, its #291 holding.
- Cigna Investments first reported a position in MetLife in Q4 2016 and has held it in 39 quarters since.
- Cigna Investments's MetLife position peaked at $2.26M in Q1 2017.
- 423 funds tracked by Wall St. Rank held MetLife as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.